9-128166300-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000372938.10(CIZ1):c.2594G>A(p.Arg865His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000168 in 1,564,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. R865R) has been classified as Likely benign.
Frequency
Consequence
ENST00000372938.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CIZ1 | NM_001131016.2 | c.2594G>A | p.Arg865His | missense_variant | 17/17 | ENST00000372938.10 | NP_001124488.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CIZ1 | ENST00000372938.10 | c.2594G>A | p.Arg865His | missense_variant | 17/17 | 1 | NM_001131016.2 | ENSP00000362029 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000527 AC: 8AN: 151850Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000623 AC: 11AN: 176556Hom.: 0 AF XY: 0.0000853 AC XY: 8AN XY: 93834
GnomAD4 exome AF: 0.000180 AC: 255AN: 1412852Hom.: 0 Cov.: 33 AF XY: 0.000163 AC XY: 114AN XY: 697554
GnomAD4 genome AF: 0.0000527 AC: 8AN: 151850Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 5AN XY: 74182
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2023 | The c.2594G>A (p.R865H) alteration is located in exon 17 (coding exon 16) of the CIZ1 gene. This alteration results from a G to A substitution at nucleotide position 2594, causing the arginine (R) at amino acid position 865 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Dystonic disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2020 | This variant is present in population databases (rs369660377, ExAC 0.03%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with CIZ1-related disease. This sequence change replaces arginine with histidine at codon 865 of the CIZ1 protein (p.Arg865His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at